- AU$639.03m
- AU$621.17m
- AU$143.84m
Brief: Polynovo Says Fire Event At Research And Development Facility
Brief: Polynovo Ltd Says Distributor Appointed For Balkan Markets
Brief: Polynovo Logs HY Group Sales Of A$68.2M
Australia's PolyNovo jumps on upbeat half-yearly sales
Brief: Polynovo Discloses Contained Fire Event At Research And Development Facility
Brief: Polynovo Says Chairman David Williams Resigns Immediately
Brief: Polynovo Posts Q1 FY26 Group Sales A$34.7M
Australia's PolyNovo jumps on group sales growth
Brief: Polynovo Appoints Bruce Peatey As CEO
Brief: Polynovo Ltd Says Not Affected By Pharma Tariffs
Brief: Polynovo Seeks Trading Halt
Australia's Polynovo tops ASX 200, eyes growth in US outpatient market
Brief: Polynovo Seeks Trading Halt
Australian healthcare stocks fall most since 2020, dragged lower by CSL
Morningstar maintains fair value estimates on Aussie health firms despite Trump's 200% tariffs plan
Australia's PolyNovo jumps on positive results from its diabetes therapy trial
Brief: Polynovo Gets TGA Clearance For Novosorb Mtx (4 Mm And 6 Mm)
Brief: Polynovo Seeks Trading Halt
Australian medical devices maker PolyNovo resumes slide on tariff fears